Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse

Diabetes Research and Clinical Practice

Volumn 54, Issue 3, 2001, Pages 145-155

  Tang, Yan ^a   Osawa, Haruhiko ^a   Onuma, Hiroshi ^a   Nishimiya, Tatsuya ^a   Ochi, Masaaki ^a   Sugita, Atsuro ^b   Makino, Hideichi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adipocyte; Gene expression; Liver; Phosphodiesterase 3B; Type 2 diabetes

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; MESSENGER RNA; PHOSPHODIESTERASE; PHOSPHODIESTERASE 3B; PROTEIN; TRIACYLGLYCEROL; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME REGULATION; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HISTOLOGY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; TRIACYLGLYCEROL BLOOD LEVEL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CHROMANS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 0034748311     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00271-6     Document Type: Article

References (61)

1. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
2. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A
3. The role of insulin-sensitive phosphodiesterase in insulin action
4. Roles of ATP in insulin actions
5. Mechanisms regulating adipocyte lipolysis
6. Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells
7. Importance of phosphodiesterase 3 for the lipolytic response in adipose tissue during insulin-induced hypoglycemia in normal man
8. Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases
9. Type III cyclic nucleotide phosphodiesterases and insulin action
10. Diabetes mellitus
11. The role of cyclic AMP in rapid and long-term regulation of gluconeogenesis and glycolysis
12. Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis
13. The insulin- and glucagon-stimulated 'densevesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity
14. Combined effects of insulin and dexamethasone on cyclic AMP phosphodiesterase 3 and glycogen metabolism in cultured rat hepatocytes
15. Inhibition of hepatic lipogenesis by cyclic-3′,5′-nucleotjde monophosphates
16. Regulation of fatty-acid metabolism by pancreatic hormones in cultured human hepatocytes
17. Cloning and expression of mouse fatty acid synthase and other specific mRNAs. Developmental and hormonal regulation in 3T3-L1 cells
18. Glucagon and N6,O2′-dibutyryl adenosine 3′:5′-monophosphate Inhibition of lipogenesis and phosphofructokinase activity of hepatocytes from meal-fed rats
19. Regulation of lipogenic enzyme gene expression by nutrients and hormones
20. Pathogenesis of NIDDM. A balanced overview
21. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications
22. What if Minkowski had been ageusic? An alternative angle on diabetes
23. Glucose-fatty acid interactions in health and disease
24. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
25. New concepts in extracellular signaling for insulin action: The single gateway hypothesis
26. Insulin resistance of fat cells from spontaneously diabetic KK mice. Analysis of insulin-sensitive phosphodiesterase
27. Effects of changes in serum insulin in response to dexamethasone and adrenalectomy on insulin-sensitive phosphodiesterase in rat fat cells
28. Insulin-sensitive phosphodiesterase and insulin receptor binding in fat cells from spontaneously obese rats
29. Phosphodiesterase activity in human subcutaneous adipose tissue in insulin- and noninsulin-dependent diabetes mellitus
30. Effect of insulin and lipolytic hormones on cyclic AMP phosphodieterase activity in normal and diabetic rat adipose tissue
31. Cyclic AMP phosphodiesterase in diabetes. Effect of glyburide
32. Cyclic nucleotide phosphodiesterase 3 expression in vivo: Evidence for tissue-specific expression of phosphodiesterase 3A or 3B mRNA and activity in the aorta and adipose tissue of atherosclerosis-prone insulin-resistant rats
33. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice
34. Metabolism of isolated fat cells
35. Characterization of insulin-sensitive phosphodiesterase in fat cells. I. Effects of salts and oxidation-reduction agents
36. Mitogen-activated protein kinase and p70 ribosomal protein S6 kinase are not involved in the insulin-dependent stimulation of cAMP phosphodiesterase kinase in rat adipocytes
37. Fatty acid synthesis in obese insulin resistant diabetic mice
38. Lipogenesis in genetically diabetic (db/db) mice: Developmental changes in brown adipose tissue, white adipose tissue and the liver
39. Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/a mice
40. Age-related decrease in sensitivity to glucagon and dibutyryl cyclic AMP inhibition of fatty acid synthesis in hepatocytes isolated from obese female Zucker rats
41. Comparative studies on fatty acid synthesis, glycogen metabolism, and gluconeogenesis by hepatocytes isolated from lean and obese Zucker rats
42. Serum hormone levels and tissue metabolism in pair-fed lean and obese Zucker rats
43. Changes in low-Km cAMP phosphodiesterase activity in liver Golgi fractions from hyper- and hypoinsulinemic rats
44. Relation between leptin and the regulation of glucose metabolism
45. Lipid abnormalities in tissues of the KKAy mouse: Effects of pioglitazone on malonyl-CoA and diacylglycerol
46. Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration byJTT-501 in obese, diabefic KKAy mouse
47. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
48. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
49. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP- inhibited cyclic nucleotide phosphodiesterase
50. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
51. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha,-beta, and -gamma in the adult rat
52. Adipocyte blood flow: Influence of age, anatomic location, and dietary manipulation
53. Effect of diet on fat cell size and hormone-sensitive lipase activity
54. Relationship between the tissue level of cyclic AMP and the fat cell size of human adipose tissue
55. Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue
56. Effect of insulin on glycerol production in obese adolescents
57. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats
58. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity
59. Fatty acids and insulin resistance
60. Toward an integrated phenotype in pre-NIDDM